Topical Ocular Anaesthetics: Powerful, Useful, and Never for Home Use

Why the cornea needs — and dreads — an anaesthetic

The cornea has no blood vessels, but it is packed with nerves. The corneal epithelium carries one of the highest densities of free sensory nerve endings anywhere in the body, fed by the ophthalmic division of the trigeminal nerve. This is deliberate: the cornea is the eye's exposed front window, and pain is its alarm system — the reflex that snaps the eyelids shut and floods the surface with tears the instant anything threatens it. That same richness of innervation, explored more fully in the Foundations chapter on corneal anatomy, is exactly why the smallest lesion hurts so much, and why any procedure on the surface is intolerable while the nerves are awake. To examine or treat a painful eye, you must first silence those nerves — briefly, and only at the surface.

The mechanism: closing the sodium gate

Topical ocular anaesthetics are simply local anaesthetics formulated as eye drops, and they work by the identical mechanism taught in the Central Nervous System section on analgesia and anaesthesia: they block voltage-gated sodium channels in the sensory nerve membrane. A pain signal is an electrical impulse, and that impulse depends on sodium rushing into the nerve. Shut the sodium gate and the impulse cannot be generated or propagated — the message of pain is never sent. Because the corneal nerve endings sit bare and superficial, a drop reaches them almost instantly: profound surface anaesthesia sets in within seconds and lasts roughly fifteen to twenty minutes, ample time for a clinic procedure but short enough that normal sensation — and the eye's protective reflexes — return soon after.

The named agents

Three drops dominate the eye clinic, and they are close cousins. Oxybuprocaine (also called benoxinate) is the workhorse for routine examination and tonometry — often combined with fluorescein dye in a single drop. Proparacaine (proxymetacaine) is the gentlest on instillation, stinging the least, which makes it the kindest choice in children and in the very inflamed eye. Tetracaine (amethocaine) is the most potent and longest-acting, but it stings the most and is a touch harsher on the epithelium, so it is favoured for minor procedures rather than casual examination. All three are esters chemically, block the same sodium channels, and differ mainly in sting, onset and duration rather than in what they fundamentally do. Whichever is chosen, the principle is identical: a single drop, instilled by a clinician, for a defined task.

The cardinal rule: never for home use

The single most important sentence in this subtopic: topical anaesthetics are a clinic-and-theatre tool, never a prescription. Because the drops abolish pain so completely, the temptation is obvious — a patient with a raw, agonising cornea would give anything to keep that relief going. But repeated instillation is directly toxic to the corneal epithelium: the anaesthetic poisons the surface cells, halts the healing they are supposed to accomplish, and disables the protective reflexes that guard the eye. Worse, by removing the pain it removes the warning signal, so the patient keeps using an eye that is quietly getting sicker. This is the mechanism behind anaesthetic-abuse keratopathy — a devastating, self-inflicted disease seen when patients get hold of the drops (from a previous clinic bottle, a relative, or the internet) and self-medicate for ongoing pain. The picture is grim: characteristic ring-shaped corneal infiltrates, a persistent epithelial defect that will not close, stromal melting, and in the worst cases perforation and permanent blindness — all in an eye that started with a minor, curable problem.

The lesser cautions — real, but not the headline

Beyond the cardinal rule, a few practical cautions matter. First, the drops sting on instillation — briefly and harmlessly, but enough to make a patient jump, so warn them (and reach for proparacaine when gentleness counts). Second, and clinically important, a numbed cornea has lost its blink and corneal (blink) reflex: the eye can no longer protect itself, so after a procedure the eye should be protected — a pad or shield until sensation returns — and the patient warned firmly not to rub it, because they could scratch an anaesthetised surface without feeling a thing. This corneal-surface vulnerability, and the healing that the anaesthetic suppresses, connects to the Ocular surface and dry-eye chapter, where epithelial integrity and repair are covered in depth. Finally, allergy to the ester anaesthetics can occur but is uncommon.

A brief contrast: anaesthesia for surgery

Topical drops numb only the surface. Deeper eye surgery may instead need regional anaesthesia — a local anaesthetic such as lidocaine or bupivacaine injected around the eye as a peribulbar, retrobulbar, or sub-Tenon block to anaesthetise and immobilise the globe. The mechanism is the same sodium-channel blockade, just delivered to the nerves behind the eye rather than the surface in front of it. But injecting a local anaesthetic carries a risk the drops do not: if the drug is accidentally placed into a blood vessel, it can reach the systemic circulation and cause local anaesthetic systemic toxicity (LAST) — the CNS and cardiac collapse covered in the Toxicology chapter, and the reason these blocks are performed by trained hands with resuscitation and intravenous lipid emulsion at the ready. It is a useful contrast: the surface drop's great danger is chronic misuse by the patient; the injected block's great danger is an acute systemic overdose in the clinic.